Tirzepatide is a dual GIP and GLP-1 receptor agonist. Where semaglutide works on one receptor, tirzepatide engages two, each tied to a hormone involved in fullness and blood sugar control. Bodi Envi's Personalized Compounded Tirzepatide Weight-Management Programs, offered to people in the Denver metro, are built around it.
Personalized Compounded Tirzepatide is a version of that active ingredient prepared by a licensed compounding pharmacy from a prescription written for an individual patient. It is taken as a weekly injection, and the starting dose and any later change are decided by the prescribing provider, not by the patient and not by Bodi Envi.
It is important to be clear about what compounded means. Personalized Compounded Tirzepatide has not been approved by the FDA and is not the same as Mounjaro® and Zepbound®, the FDA-approved products. Compounded drugs are not reviewed by the FDA for safety, effectiveness or quality before they are marketed. Brand names are trademarks of their respective owners. Compounding pharmacies are regulated by state boards of pharmacy for sterile compounding and are required to follow United States Pharmacopeia standards.